Medtronic (BUE:MDT) Cyclically Adjusted FCF per Share: ARS1,730.81 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:MDT Medtronic PLC BUE:MDT
66 GF Score
Price ARS32,720.00
GF Value ARS38,116.80
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cyclically Adjusted FCF per Share?

Medtronic BUE:MDT 66 Cyclically Adjusted FCF per Share is ARS1,730.81 as of Apr. 2026. GuruFocus rates BUE:MDT with a GF Score™ of 66/100 and a GF Value™ of ARS38,116.80 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Medtronic's adjusted free cash flow per share for the three months ended in Apr. 2026 was ARS4,504.154. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ARS1,730.81 for the trailing ten years ended in Apr. 2026.

During the past 12 months, Medtronic's average Cyclically Adjusted FCF Growth Rate was 4.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 2.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Medtronic was 30.10% per year. The lowest was 1.00% per year. And the median was 9.65% per year.

As of today (2026-07-20), Medtronic's current stock price is ARS32720.00. Medtronic's Cyclically Adjusted FCF per Share for the quarter that ended in Apr. 2026 was ARS1,730.81. Medtronic's Cyclically Adjusted Price-to-FCF of today is 18.90.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medtronic was 34.08. The lowest was 15.74. And the median was 23.22.


Medtronic  (BUE:MDT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medtronic's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=32720.00/1730.81
=18.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Medtronic was 34.08. The lowest was 15.74. And the median was 23.22.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Medtronic Cyclically Adjusted FCF per Share Related Terms


Medtronic Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Medtronic's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cyclically Adjusted FCF per Share Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 222.13 500.88 1,197.42 1,314.65 1,730.81

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,314.65 1,500.03 1,660.17 1,650.43 1,730.81

BUE:MDT vs SYK, BSX, EW: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted Price-to-FCF falls into.


BUE:MDT
66GF Score
Medtronic PLC BUE:MDT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medtronic's adjusted Free Cash Flow per Share data for the three months ended in Apr. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=4504.154/128.4300*128.4300
=4,504.154

Current CPI (Apr. 2026) = 128.4300.

Medtronic Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201607 26.059 100.872 33.178
201610 26.536 99.776 34.157
201701 40.543 99.178 52.501
201704 32.172 100.773 41.002
201707 11.880 100.673 15.156
201710 17.123 100.374 21.909
201801 50.733 99.377 65.565
201804 21.962 100.374 28.101
201807 59.689 101.470 75.548
201810 58.056 101.271 73.626
201901 97.500 100.075 125.126
201904 112.211 102.068 141.192
201907 75.960 101.969 95.672
201910 135.002 101.969 170.036
202001 187.265 101.371 237.253
202004 106.414 101.969 134.029
202007 -5.850 101.570 -7.397
202010 178.181 100.474 227.759
202101 247.156 101.171 313.748
202104 184.962 103.065 230.482
202107 129.054 103.763 159.734
202110 218.339 105.557 265.651
202201 288.657 106.255 348.900
202204 275.836 110.242 321.345
202207 123.474 113.262 140.009
202210 132.491 115.315 147.560
202301 329.799 114.470 370.020
202304 552.520 118.213 600.274
202307 200.541 119.903 214.802
202310 105.113 121.111 111.465
202401 2,583.737 119.179 2,784.296
202404 3,046.175 121.232 3,227.049
202407 656.318 122.560 687.753
202410 835.154 121.956 879.487
202501 3,426.215 121.473 3,622.438
202504 3,743.419 123.888 3,880.658
202507 1,197.862 124.613 1,234.557
202510 1,021.505 125.410 1,046.104
202601 5,151.398 124.690 5,305.911
202604 4,504.154 128.430 4,504.154

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ARS1,730.81 mean?
Medtronic (BUE:MDT) has a Cyclically Adjusted FCF per Share of ARS1,730.81 as of Apr. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Medtronic and its competitors.
Is Medtronic's Cyclically Adjusted FCF per Share too high?
Medtronic's current Cyclically Adjusted FCF per Share is ARS1,730.81. Overall, Medtronic has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Cyclically Adjusted FCF per Share compare to SYK and BSX?
Medtronic's Cyclically Adjusted FCF per Share of ARS1,730.81 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Medtronic and its competitors. Medtronic's current Cyclically Adjusted FCF per Share is ARS1,730.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BUE:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is ARS38,116.80, compared to a current price of ARS32,720.00 — trading 14.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ARS1,730.81. Medtronic's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Medtronic (BUE:MDT), the current Cyclically Adjusted FCF per Share is ARS1,730.81 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BUE:MDT) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of ARS32,720.00 is trading 14.2% below its estimated GF Value™ of ARS38,116.80. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BUE:MDT:

  • Cyclically Adjusted FCF per Share: ARS1,730.81
  • GF Value™: ARS38,116.80 vs. price of ARS32,720.00 (14.2% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the BUE:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
66GF Score

Get the complete analysis for BUE:MDT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS32,720.00
Price
ARS38,116.80
GF Value